Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 1436  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission




 
ORIGINAL ARTICLE
Year : 2010  |  Volume : 2  |  Issue : 4  |  Page : 365-368 Table of Contents     

Spectrophotometric methods for determination of zolpidem tartrate in tablet formulation


1 Department of Pharmaceutical Chemistry, Swami Keshvanand Institute of Pharmacy, Bikaner 334001, India
2 Department of Pharmaceutical Chemistry, BNPG Girls College of pharmacy, Udaipur, Rajasthan, India

Date of Submission29-Mar-2010
Date of Decision10-May-2010
Date of Acceptance26-Jun-2010
Date of Web Publication28-Oct-2010

Correspondence Address:
Rajiv Chomwal
Department of Pharmaceutical Chemistry, Swami Keshvanand Institute of Pharmacy, Bikaner 334001
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0975-7406.72142

Rights and Permissions
   Abstract 

Aim : The study aims to develop simple, sensitive, rapid, accurate and precise spectrophotometric method for estimation of Zolpidem tartrate in tablet dosage forms. Materials and Methods : For method I, II, III and IV in a series of 10 ml volumetric flask, aliquots of standard drug solution (100 μg/ml) in 0.1N HCl were transferred and diluted with same so as to give several dilutions in concentration range of 5-30 μg/ml, 5-30 μg/ml, 10-50 μg/ml and 5-40 μg/ml respectively of zolpidem tartrate. To 5 ml of each dilution taken in a separating funnel, (5 ml of bromo phenol red, bromo cresol purple, bromo cresol green and bromo phenol blue for method I, II, III and IV respectively) reagent and 5 ml of chloroform was added. Reaction mixture was shaken gently for 5 min and allowed to stand so as to separate aqueous and chloroform layer. Absorbance maxima measured at 407 nm, 417 nm, 412 nm and 415 nm for method I, II, III and IV respectively. Results : The recovery studies were found close to 100 % that indicates accuracy and precision of the proposed methods. The statistical analysis was carried out and results of which were found satisfactory. Standard deviation values were found low that indicated reproducibility of the proposed methods. Conclusion : Based on results the developed methods could be used for routine estimation of zolpidem tartrate from tablet formulations.

Keywords: Spectrophotometric, quantitative estimation, zolpidem tartrate


How to cite this article:
Chomwal R, Kumar A, Goyal A. Spectrophotometric methods for determination of zolpidem tartrate in tablet formulation. J Pharm Bioall Sci 2010;2:365-8

How to cite this URL:
Chomwal R, Kumar A, Goyal A. Spectrophotometric methods for determination of zolpidem tartrate in tablet formulation. J Pharm Bioall Sci [serial online] 2010 [cited 2022 May 23];2:365-8. Available from: https://www.jpbsonline.org/text.asp?2010/2/4/365/72142

Zolpidem tartrate, chemically bis [N,N dimethyl-2[6-methyl-2-(4-methyl phenyl)] imidazo[ 1, 2-a] pyridine-3-yl]acetamide](2R,3R)-2,3dihydroxybutane dioate, is a hypnotic agent. [1] It produces agonistic effect on GABA A receptors and it is used in the treatment of insomnia. It is official in BP 1 and Merck Index 2 which describes liquid chromatographic method for its quantitation. [1],[2] Literature survey reveals that four HPLC methods, [3],[4],[5],[6] one potentiometric method [7] have been developed for the estimation of zolpidem tartrate in human serum and tablet formulation. The objective of the present investigation has been to develop simple, accurate and economical visible spectrophotometric methods for quantitation of zolpidem tartrate in tablet formulation.


   Materials and Methods Top


Shimadzu UV 1700, UV/Vis double beam spectrophotometer with spectral band width of 1 nm, wavelength accuracy of ± 0.3 nm and 1.0 cm matched quartz cells was used for analytical method development. All the chemicals and reagents used were of analytical grade. Bromo phenol red reagent (Merck Germany), bromo cresol purple, bromo cresol green, bromo phenol blue (Loba Chemie, Mumbai) reagents were prepared in double distilled water. All the reagents were extracted several times with chloroform so as to remove chloroform soluble impurities. Tablet formulations of zolpidem tartrate [Nitrest (Sun Pharmaceutical Industries, Dadra), Zolfresh (Acme formulation Pvt. Ltd., Solan)] were procured from local pharmacy. Standard solution of zolpidem tartrate was prepared by dissolving 10 mg in 100 ml of 0.1N HCl solution to give stock solution of concentration 100 μg/ml of drug.

Procedure for preparation of calibration curve

For method I, in a series of 10 ml volumetric flask, aliquots of standard drug solution

(100 μg/ml) in 0.1N HCl solution were transferred and diluted with same so as to give several dilutions in concentration range of 5-30 μg/ml of zolpidem tartrate. To 5 ml of each dilution taken in a separating funnel, 5 ml of bromo phenol red (0.2 % w/v) reagent and 5 ml of chloroform was added. Reaction mixture was shaken gently for 5 min and allowed to stand so as to separate aqueous and chloroform layer. The chloroform layer was separated out and an absorbance maximum was measured at 407.0 nm [Figure 1] against a reagent blank. Calibration curve was plotted [Figure 1] between concentration of zolpidem tartrate and measured absorbance. Spectral characteristics of zolpidem tartrate are given in [Table 1].
Table 1 :Spectral characteristics of zolpidem tartrate

Click here to view
Figure 1 :UV spectrum of zolpidem tartrate with bromo phenol red reagent

Click here to view


For method II, in a series of 10 ml volumetric flask, aliquots of standard drug solution (100 μg /ml) in 0.1NHCl solution were transferred and diluted with same so as to give several dilutions in concentration range of 5-30 μg/ml of zolpidem tartrate. To 5 ml of each dilution taken in a separating funnel, 5 ml of bromo cresol purple reagent (0.5 % w/v) and 5 ml of chloroform was added. Reaction mixture was shaken gently for 5 min and allowed to stand so as to separate aqueous and chloroform layer. The chloroform layer was separated out and an absorbance maximum was measured at 417.0 nm [Figure 2] against a reagent blank. Calibration curve was plotted [Figure 2] between concentration of zolpidem tartrate and measured absorbance. Spectral characteristics of zolpidem tartrate are given in [Table 1].
Figure 2 :UV spectrum of zolpidem tartrate with bromo cresol purple reagent

Click here to view


For method III, in a series of 10 ml volumetric flask, aliquots of standard drug solution (100 μg/ ml) in 0.1N HCl solution were transferred and diluted with same so as to give several dilutions in concentration range of 10-50 μg/ml of zolpidem tartrate. To 5 ml of each dilution taken in a separating funnel, 5 ml of bromo cresol green reagent (0.2 % w/v) and 5 ml of chloroform was added. Reaction mixture was shaken gently for 5 min and allowed to stand so as to separate aqueous and chloroform layer. The chloroform layer was separated out and an absorbance maximum was measured at 412.0 nm [Figure 3] against a reagent blank. Calibration curve was plotted [Figure 3] between concentration of zolpidem tartrate and measured absorbance. Spectral characteristics of zolpidem tartrate are given in [Table 1].
Figure 3 :UV spectrum of zolpidem tartrate with bromo cresol green reagent

Click here to view


For method IV, in a series of 10 ml volumetric flask, aliquots of standard drug solution (100μg/ml) in 0.1N HCl solution were transferred and diluted with same so as to give several dilutions in concentration range of 5-40 μg/ml of zolpidem tartrate. To 5 ml of each dilution taken in a separating funnel, 5 ml of bromo phenol blue reagent (0.2 % w/v) and 5 ml of chloroform was added. Reaction mixture was shaken gently for 5 min and allowed to stand so as to separate aqueous and chloroform layer. The chloroform layer was separated out and an absorbance maximum was measured at 412.0 nm [Figure 4] against a reagent blank. Calibration curve was plotted [Figure 4] between concentration of zolpidem tartrate and measured absorbance. Spectral characteristics of zolpidem tartrate are given in [Table 1].
Figure 4 :UV spectrum of zolpidem tartrate with bromo phenol blue reagent

Click here to view


Procedure for analysis of tablet formulation

For analysis of tablet formulation, 20 tablets (5 mg and 10 mg) of zolpidem tartrate were accurately weighed and finely powdered. An accurately weighed powdered sample 10 mg of zolpidem tartrate was taken in a 100 ml volumetric flask containing 40 ml of 0.1N HCl solution, sonicated for 10 min. The resultant was filtered through Whatman filter paper no. 41 into another 100 ml volumetric flask. The filter paper was washed several times with 0.1N HCl solution. The washings were added to the filtrate and final volume was made up to the mark with 0.1N HCl solution.

For method I, 1 ml of filtrate of the sample solution was diluted to 10 ml with 0.1N HCl solution. These were treated as per the procedure for preparation of calibration curve and amount of the drug present in sample was computed from respective calibration curve.

For method II, 1 ml of filtrate of the sample solution was diluted to 10 ml with 0.1N HCl solution. These were treated as per the procedure for preparation of calibration curve and amount of the drug present in sample was computed from respective calibration curve. For method III, 3 ml of filtrate of the sample solution was diluted to 10 ml with 0.1N HCl solution. These were treated as per the procedure for preparation of calibration curve and amount of the drug present in sample was computed from respective calibration curve. For method IV, 1 ml of filtrate of the sample solution was diluted to 10 ml with 0.1N HCl solution. These were treated as per the procedure for preparation of calibration curve and amount of the drug present in sample was computed from respective calibration curve.

The procedure of analysis from tablet formulations for all the methods was repeated five times with two different tablet formulations and results are reported in [Table 2].
Table 2 :Results of analysis and recovery studies of commercial formulations of zolpidem tartrate

Click here to view


Recovery studies

Recovery studies were carried out for both the developed methods by addition of known amount of standard drug solution of zolpidem tartrate to pre-analyzed tablet sample solution at three different concentration levels. The resulting solutions were analyzed by proposed methods. The recovery was in the range of 99-100 % for method I, 98-100 % for method II, 99-100 % for method III and 99-100% for method IV. The results of recovery studies are reported in [Table 2].


   Result and Discussion Top


The development of a new dosage form involves a number of stages and the analytical methods that are specific, accurate and precise, plays a vital role in many of the essential features required for an identical analytical system, have been adopted in a wide range of pharmaceutical analysis. Taking into account the above, four accurate, simple, precise, economical and rapid visible spectrophotometric assay methods were developed for the quantitative estimation of zolpidem tartrate in tablet dosage forms.

The proposed methods obeyed Beer's law in the concentration range of 5-30 μg/ml with bromo phenol red 5-30 μg/ml with bromo cresol purple, 10-50 μg/ml with bromo cresol green and 5-40 μg/ml with bromo phenol blue reagent. The recovery studies were carried out by standard addition method and were found close to 100 % that indicates accuracy and precision of the proposed methods. The statistical analysis was carried out and results of which were found satisfactory. Standard deviation values were found to be low that indicated reproducibility of the proposed methods. It was observed that excipients did not interfere with the determination of zolpidem tartrate. Hence, these developed methods could be used for routine estimation of zolpidem tartrate from tablet formulations.


   Conclusion Top


The developed methods were found to be precise and accurate. The methods can be used for the routine spectrophotometric analysis of zolpidem tartrate in pharmaceutical preparations. Despite the low concentration of zolpidem tartrate, these methods were successfully used to estimate the amount of zolpidem tartrate present in the tablet without the addition of internal standard or prior separation. Moreover, the developed methods have the advantages of simplicity, convenience and quantification of zolpidem tartrate for the assay of their dosage form.

 
   References Top

1.Budavari S, editor. The Merck Index. 12 th ed. White house Station (NJ): Merck and Co Inc; 1996. p.10322.  Back to cited text no. 1
    
2.British Pharmacopoeia. Vol. 2. United Kingdom: The Stationary office on the behalf of MHRA; 2007. p. 2193.  Back to cited text no. 2
    
3.Nirogi RV, Kandikere VN, Shrivasthava W, Mudigonda K. Quantification of zolpidem tartrate in human plasma by high performance liquid chromatography with fluorescence detection, J Chromat B 2004;811:59-63.  Back to cited text no. 3
    
4.Laviana L, Mangas C, Mari FF, Bayod M. Determination and in process control synthesis by HPLC. J Pharm Biomed Anal 2004;36:925-8.  Back to cited text no. 4
    
5.Ring PR, Bostick JM. Validation of a method for the determination of zolpidem tartrate in human plasma using LC with fluorescence detection. J Pharm Biomed Anal 2000;22:495- 504.  Back to cited text no. 5
[PUBMED]  [FULLTEXT]  
6.Kintz P, Villain M, Ludes B. Testing for zolpidem in oral fluid by liquid chromatography-tandem mass spectrometry, J Chromat B 2004;3:1016-20.  Back to cited text no. 6
    
7.Kelani KM. Selective potentiometric determination of zolpidem hemitartrate in tablets and biological fluids by using polymeric membrane electrode, J AOAC Int 2004;87:1309-18.  Back to cited text no. 7
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]
 
 
    Tables

  [Table 1], [Table 2]


This article has been cited by
1 Sensitive sensor based on TiO2NPs nano-composite for the rapid analysis of Zolpidem, a psychoactive drug with cancer-causing potential
Esmail Sohouli, Masoumeh Ghalkhani, Faezeh Shahdost-fard, Elnaz Marzi Khosrowshahi, Mehdi Rahimi-Nasrabadi, Farhad Ahmadi
Materials Today Communications. 2021; 26: 101945
[Pubmed] | [DOI]
2 Electrooxidation of Zolpidem and its Voltammetric Quantification in Standard and Pharmaceutical Formulation using Pencil Graphite Electrode
A. Naeemy,E. Sedighi,A. Mohammadi
Journal of Electrochemical Science and Technology. 2016; 7(1): 68
[Pubmed] | [DOI]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
    Materials and Me...
    Result and Discu...
    Conclusion
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed5020    
    Printed123    
    Emailed2    
    PDF Downloaded181    
    Comments [Add]    
    Cited by others 2    

Recommend this journal